We are writing to let you know about a new one-page Paxlovid Treatment Guide with the latest information about Paxlovid (nirmatrelvir/ritonavir), which continues to be the preferred treatment for most patients with mild-to-moderate COVID-19 infection. Paxlovid is in ample supply and widely available in Massachusetts.
It is our shared responsibility to ensure that Paxlovid and other COVID-19 treatments are offered to all patients eligible to receive them. Any patient 12 years or older who tests positive for COVID-19 should be evaluated and prescribed Paxlovid or other treatment, as appropriate.
Print Page
Email to a Friend